Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3616 AL 3630

The Comorbidity of AD and PD: Exploring Clinical, Pathological, and Biomarker Interactions

Zhang QL, Liu Y, Tu T, Yan XX.

Aging Dis. 2025 Jun 14. doi: 10.14336/AD.2025.0301. Online ahead of print.

The Mitochondrial Foundations of Parkinson's Disease: Therapeutic Implications

Soman SK, Woodruff MRJ, Dagda RK.

Aging Dis. 2025 Apr 28;16(5):2695-2720. doi: 10.14336/AD.2025.0440.

Pick's disease presenting as progressive apraxia of speech: Atypical clinical and neuroimaging features in three autopsy-confirmed cases

Jones KE, Graff-Radford J, Utianski RL, Duffy JR, Clark HM, Machulda MM, Dickson DW, Whitwell JL, Josephs KA, Botha H.

Clin Neurol Neurosurg. 2025 Sep;256:109018. doi: 10.1016/j.clineuro.2025.109018. Epub 2025 Jun 18.

Aquatic and land-based therapies were ineffective in improving muscle strength and morphological parameters in Parkinson: A randomized trial

Strey B, Aita JSB, Frata B, Cechetti F, Pinto RS.

Clin Biomech (Bristol). 2025 Jul;127:106594. doi: 10.1016/j.clinbiomech.2025.106594. Epub 2025 Jun 13.

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study

Orrú CD, Vaughan DP, Vijiaratnam N, Real R, Martinez-Carrasco A, Fumi R, Jensen MT, Hodgson M, Girges C, Gil-Martinez AL, Stafford EJ, Wu L, Lerche S, Wurster I, Groveman BR, Hughson AG, Ansorge O, Quaegebeur A, Allinson KSJ, Warner TT, Jaunmuktane Z, Misbahuddin A, Leigh PN, Ghosh BCP, Bhatia KP, Church A, Kobylecki C, Hu MTM, Rowe JB, Parchi P, Brockmann K, Foltynie T, Morris HR, Caughey B, Jabbari E.

Lancet Neurol. 2025 Jul;24(7):580-590. doi: 10.1016/S1474-4422(25)00157-7.

A community-led initiative to de-risk and advance Parkinson's disease therapeutic targets

Vaiana A, Behr J, Birol R, Blauwendraat C, Casey B, Chowdhury K, Citron M, Crapser J, Dardov V, Ducotterd F, Dumanis S, Dunlop J, Durborow M, Fiske B, Golden J, Hannestad J, Hung W, Kemp J, Kleiman R, Knight A, Koemeter-Cox A, Leuchter B, Logsdon BA, Marreiros R, Miller JE, Mitchell A, Mukherjee P, Navarro G, Nelson MR, Nikolich K, Otis T, Polinski N, Rastegar-Pouyani S, Reith AD, Riley E, Rubin L, Ryten M, Sadick J, Schwabe T, Sherer T, Silvergleid S, Singleton A, St Clair L, Stoehr J, Stone DJ, Sullivan J, Tanenbaum N, Tinelli E, Trimble K, Wang Y, Weninger S, Wiggenhauser N, Wood S, Schoepp D, Buggia-Prevot V, Padmanabhan S, Skibinski G.

NPJ Parkinsons Dis. 2025 Jun 20;11(1):179. doi: 10.1038/s41531-025-01039-3.

A novel fusion architecture for detecting Parkinson's Disease using semi-supervised speech embeddings

Adnan T, Abdelkader A, Liu Z, Hossain E, Park S, Islam MS, Hoque E.

NPJ Parkinsons Dis. 2025 Jun 20;11(1):176. doi: 10.1038/s41531-025-00956-7.

[Autophagy Impairment in Parkinson's Disease: Approaches to Therapy]

Usenko TS.

Mol Biol (Mosk). 2025 Jan-Feb;59(1):60-79. doi: 10.31857/S0026898425010053.

More Than Three Decades After Discovery of the Neuroprotective Effect of PACAP, What Is Still Preventing Its Clinical Use?

Cherait A, Xifró X, Reglodi D, Vaudry D.

J Mol Neurosci. 2025 Jun 21;75(3):80. doi: 10.1007/s12031-025-02366-z.

Clonidine for Management of Agitation in Delirious Patients

Rowland DC, Waldvogel NJ.

Curr Psychiatry Rep. 2025 Aug;27(8):464-470. doi: 10.1007/s11920-025-01617-5. Epub 2025 Jun 21.

Novel Kinesin Family Member 1A Variants Linked to Atypical Parkinsonism Elicit Altered Neuronal Transactive Response DNA Binding Protein 43 kDa Interactions and Dendritic Atrophy

Homayoun H, DeChellis-Marks MR, Kofler J, Fricklas G, Gleixner AM, Yeh FC, Lacomis D, Chu CT, Donnelly CJ.

Am J Pathol. 2025 Nov;195(11):2161-2175. doi: 10.1016/j.ajpath.2025.05.018. Epub 2025 Jun 19.

Beyond neurons: How does dopamine signaling impact astrocytic functions and pathophysiology?

Favetta G, Bubacco L.

Prog Neurobiol. 2025 Aug;251:102798. doi: 10.1016/j.pneurobio.2025.102798. Epub 2025 Jun 19.

Complement therapeutics in neurodegenerative diseases

Zelek WM, Tenner AJ.

Immunobiology. 2025 Jul;230(4):153089. doi: 10.1016/j.imbio.2025.153089. Epub 2025 Jun 16.

Unconsciousness reshapes the oscillatory topography of the subthalamic nucleus: A comparative study

Dubach L, Averna A, Alva L, Debove I, Bernasconi E, Sousa M, Petermann K, Lachenmayer ML, Krack P, Nowacki A, Pollo C, Krejci V, Tinkhauser G.

Neurobiol Dis. 2025 Sep;213:107009. doi: 10.1016/j.nbd.2025.107009. Epub 2025 Jun 20.

Driving Therapeutic Innovation in Neurodegenerative Disease With Hydrogen Deuterium eXchange Mass Spectrometry

Pierangelini A, Kessler BM, O'Brien DP.

Mol Cell Proteomics. 2025 Aug;24(8):101017. doi: 10.1016/j.mcpro.2025.101017. Epub 2025 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias